HealthUS regulator warns of potential eye-condition risk linked to GLP-1 drugs
The US health regulator notified patients and healthcare providers of a potential higher risk of a serious eye condition associated with GLP-1 drugs used for weight loss and diabetes.
US regulator warns of potential eye-condition risk linked to GLP-1 drugs
